The medspa was allegedly using compounded forms of semaglutide and tirzepatide that were not intended for human consumption and meant for research purposes only, violating the states Deceptive Trade Practices Act, the publication reported
Within-class differences further inform selection, as GLP-1RAs are more strongly associated with reductions in atherosclerotic events, while SGLT2is demonstrate greater benefit in HF and kidney outcomes, with modest blood pressure-lowering effects that may contribute to cardiovascular risk reduction [9]
5 Patients considering GLP-1 therapy should undergo a thorough medical evaluation to assess suitability and monitor for potential side effects
10.1007/978-1-4614-6130-2_31 28 EmbersonJ.LeesK
Fisetin is a senotherapeutic that extends health and lifespan
Wright Currently approved GLP-1 receptor agonists for treating type 2 diabetes and, in some cases, obesity, include dulaglutide (Trulicity, Eli Lilly & Co.), exenatide (Byetta, Amylin Pharmaceuticals